Meeting
2018 ASCO Annual Meeting
Concordance of genomic alterations (GA) in synchronous tumor biopsies (tBx) and circulating tumor (ct) DNA from metastatic breast cancer (MBC) patients (pts).
Authors
Mafalda Oliveira
Medical Oncology Department, Breast Cancer Group, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
Mafalda Oliveira , Meritxell Bellet , Anna Suñol , Fiorella Ruiz-Pace , Patricia Gomez , Santiago Escrivá , Laia Garrigós , Esther Zamora , Marta Capelán , Analía Azaro , Miriam Arumí , Carolina Ortiz , Judit Matito , Roberta Fasani , Francesco M Mancuso , Martin Espinosa , Paolo Nuciforo , Rodrigo Dienstmann , Ana Vivancos , Cristina Saura
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Metastatic
Track
Breast Cancer
Sub Track
Other Breast Cancer Subtypes
Citation
J Clin Oncol 36, 2018 (suppl; abstr 1073)
DOI
10.1200/JCO.2018.36.15_suppl.1073
Abstract #
1073
Poster Bd #
154
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
ESR1 mutational landscape and impact of co-existing resistance variants on clinical outcomes in patients with metastatic breast cancer.
First Author: Arielle J Medford
Poster
2020 ASCO Virtual Scientific Program
The landscape of genomic alterations detected in serial circulating tumor DNA (ctDNA) in clinical progressive metastatic breast cancer.
First Author: Saya Jacob
Poster
2020 ASCO Virtual Scientific Program
Cell-free DNA comparative analysis of hormone receptor-positive, first-line metastatic breast cancer genomic landscape in the United States and China.
First Author: Huiping Li
Poster
2017 Genitourinary Cancers Symposium
Dissecting the genomic landscape of metastatic bladder cancer using circulating tumor DNA.
First Author: Werner J. Struss